GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

NCT07297667 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Alveolar Soft Part Sarcoma
Renal Cell Carcinoma
Triple Negative Breast Cancer

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: GCAR1

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]
[object Object]